Ozempic is FDA-approved specifically for the treatment of type 2 diabetes but is commonly prescribed off-label for weight management
However, its effectiveness in reducing body weight has led to its approval as a chronic weight management drug
Prediction 1: More Lawsuits Due to Adverse Effects Back in March 2024, USA Today reported: More than five dozen lawsuits accuse Novo Nordisk or Eli Lilly of failing to notify patients about the side effects of their popular diabetes or weight-loss drugs. As of the first of this month 16 months later that number has jumped to 1,997 pending lawsuits against Wegovy and other GLP-1 drugs
(3) comparison (control): assessing a group of patients as control group not receiving GLP-1 agonists (including placebo, other medications, lifestyle or diet intervention)
Individuals taking GLP-1s in this study reported lower subjective craving for alcohol, so it would be reasonable to think that these drugs could be helpful for those who have problems with alcohol, though larger studies are still needed. Why Might GLP-1s Affect How People Metabolize Alcohol
Notes: A single 100mg epithalon course under the Russian Protocol requires two 50mg epithalon vials
